In order to identify the existence of Panax species in herbal medicine preparations, the Ginseng specific marker primer was selected and created based on the sequence of Korean ginseng DNA fragment, 359 bp. The gradient PCR was performed on 40 types of the herbal medicines including the 7 types of Araliaceae that are in the same family with the Panax ginseng using the created Ginseng maker primer. As result, Panax notoginseng (Chinese), Panax japonicus (Japanese) and Panax quinquefolius (American), along with Panax ginseng (Korean) were the only ones amplified. However, in the case of Atractylodes lancea, one of the herbal medicines not categorized as Panax species, the DNA was prominently amplified by the Ginseng marker primer. The sequence of the amplified DNA of Atractylodes lancea was identified, resulting in enabling the differentiation from the Panax species by the Restriction Fragment Length Polymorphisms (RFLP) method. In addition, the results of the gradient PCR performed on the herbal medicine preparations that consists of Panax ginseng showed that 290 bp size of the original DNA fragments of Panax ginseng was amplified on the herbal medicine preparations containing Panax ginseng. Therefore, these results suggest a possibility of creating a new testing method for identifying specific herb medicines using the gradient PCR, a molecular biological method not only on Panax ginseng, but also on other herbal medicines and herbal medicine preparations.
Molecular biological methods using Random Amplification of Polymorphic DNA (RAPD), 1) Sequence Characterized Amplified Region (SCAR) markers 2) , Restriction Fragment Length Polymorphisms (RFLP) 3) and Amplified Fragment Length Polymorphisms (AFLP) 4) are frequently employed to analyze the genetic variation between species or individual organisms. Herbal medicinal products vary in composition and properties, unlike conventional pharmaceutical products. Correct identification and quality control of the starting material is, therefore, an essential prerequisite for ensuring their quality, safety and efficacy.
Most regulatory guidelines and pharmacopoeias recommend macroscopic and microscopic evaluation and chemical profiling of plant materials for purposes of quality control and standardization. Such evaluation is based on comparing visual parameters and microscopic properties with standard reference material. However, these criteria are subjective, and substitutes or adulterants may closely resemble the genuine material. Chemical profiling methods such as Thin Layer Chromatograph (TLC) and High Performance Thin Layer Chromatograph (HPTLC) are routinely used for qualitative determination of herb medicines. Nevertheless the use of chromatographic techniques and marker compounds to standardize botanical preparations has limitations because of the varied sources and chemical complexity of such preparations. In particular, many extrinsic factors such as methods of cultivation, harvesting, drying and storing may affect the ultimate chemical profile of a given herb. 5) Moreover since many associated agents and bonding agents are mixed with herbal extracts at 90-100°C for 2-4 h, it is difficult to identify the plants involved from the final products (extracts, capsules, liquids) by TLC.
The analysis of genomic DNA, on the other hand, has the advantages of being applicable to all parts of a plant and not being affected by conditions of culture. 6) Genetic analysis has been frequently used to accurately identifying the origin of herbal medicines. Medicinal products whose origins are often controversial, such as Angelica gigas root, Saposhnikovia root, Coix seed, Citrus unshiu peel, Angelica decursiva radix, Magnolia bark, Polygonatum rhizome, and Bupleurum root, have been intensively studied and other herbal medicines have also been analyzed by RAPD. 6) Generally, DNA is unstable to heat treatment and destroyed at temperatures over 75°C. Hence, in the case of herbal medicine extracts that are prepared at a temperature in excess of 90°C for two hours, most of the DNA should be modified or damaged even though some DNA may remain. Therefore, it has been considered impossible to trace the origin of plant extracts by molecular biological methods such as PCR and there have been few if any attempts to use PCR to identify the origin of herbal medicine preparations. However, as a result of the progress in molecular biological methods, PCR approaches for detecting Genetically Modified Organisms (GMO) have recently been developed. 7) In GMO Products, only specific genes of bean and corn were amplified by PCR, and thereby this result verified the existence of GMO. PCR methodology has been used to identify GMOs not only in raw materials but also in manufactured food products that have been treated at 122°C for 12 min and at 132°C for 16 s. 7) We previously extracted, and amplified by RAPD, genomic DNA from the delegate Ginseng of each country: Panax ginseng (Korean), Panax notoginseng (BURK) F. H. CHENG (Chinese), Panax japonicus (Japanese), and Panax quinquefolius L. (American). We identified OPA 5 (Operon random primer type A 5) that reacts specifically with the Panax species of each country. 8 (SIM2) that specifically amplified that fragment from the DNA of Panax species.
In this study, we show that gradient PCR using the SIM2 primer can uniquely identify Panax species in herbal medicines, and herbal medicinal preparations containing diverse components.
MATERIALS AND METHODS

Plant Materials
The roots of six types of Panax species such as the Panax Ginseng C. A. MEYER (Korean), Panax notoginseng (BURK) F. H. CHENG (Chinese), Panax japonica (Japanese), and Panax quinquefolium L. (American, Canadian) were used in this experiment. Among these, the Panax notoginseng (Chinese: circulating product in the market place) had an obscure origin, but was compared to other Panax species. In the case of the Panax quinquefolius (American), the verified standard samples were provided to use in the experiment by the Korea ginseng & Tobacco research institute. The Panax japonicus (Japanese) were used in the experiment after an expert confirming those bought in Japan. Panax species were identified by discrimination specialist-Professor Chang Soo Yook (Kyung Hee University). The Panax species of each country used in this experiment were grinded finely and filtered by a size 100 sieve, and only the finest powder was used. In addition, for the herbal medicine preparations, 14 items including the Bak-Ho-GaInsam-Tang ( ), a resource containing Panax ginseng, and 16 items including Eun-Kyo-San ( ), a resource without ginseng, all of which being available in the marketplace, were bought from Korean pharmacy (Boryung Pharmacy, Seoul) and used in the experiment.
DNA Purification In order to isolate DNA in herbal medicinal preparations, the preparations were grinded into powder. 5-10 g of each sample powder was extracted in 100 ml of distillated water for 15 min by ultra-sonication and centrifuged for three times. The DNA in the dried pellet was isolated using CTAB buffer method. 8, 9) Cloning of the DNA Fragment of Panax ginseng Amplified by OPA-5 and Its Sequencing The DNA fragment (359 bp) of Panax ginseng amplified by Operon random primer Type A5 (OPA5) was cloned using PCR-TOPO cloning kit (Invitrogen, U.S.A.) and its sequences were identified using automatic DNA sequencing method.
8)
Ginseng Marker Primer Three ginseng marker primers (SIM2, SIMGS, SIMSP) based on the known Panax ginseng gene region 8) were synthesized using "Primer3" primer synthesizing program. SIMSP primer (Forward: 5Ј-AGGGGTC-TTGCTATAGCGGAAC-3Ј, Reverse: 5Ј-AGTCTTAATTTC-ATATTTTCGTATG-3Ј), SIMGS primer (Forward: 5Ј-CTA-TAGCGGAACACGAGGGA-3Ј, Reverse: 5Ј-AGTTCGCC-ACCAACTGTAGC-3Ј) and SIM2 primer (Forward: 5Ј-CT-ATAGCGGAACACGAGGGA-3Ј, Reverse: 5Ј-ATACCAAG-CGCTCGCTAATG-3Ј) were synthesized for the amplification of DNA fragment 359 bp, 210 bp and 290 bp of Panax ginseng, respectively (Fig. 2) .
Gradient PCR on Herbal Medicinal Preparations Containing Ginseng Species PCR was performed in herbal medicine preparations using Ginseng marker primer (SIM2). The final 20 ml of the volume were used for the reaction using PCR pre-mix kit for the gradient PCR. The initial cycle was 5 min at 94°C for predenaturation (1st step), and followed by 35 cycles of 1 min at 94°C for denaturation (2nd step), reacted 30 s at 50-60°C of 12 steps (3rd step) and 2 min at 72°C for extension. 
RESULTS AND DISCUSSION
Cloning and Sequencing of OPA5 Product
The Panax ginseng DNA fragment (359 bp) that were amplified by the OPA5 primer were cloned into the TA cloning vector and the amplified DNA region of the Panax species was sequenced. The homology of the identified sequence region on Panax species was searched in Gene bank and the result indicates a 91% homology with the tobacco chloroplast DNA (Fig. 1) . In addition, the identified sequence of Panax ginseng DNA fragments (359 bp) are generally the DNA region existing in the chloroplast of plants, also exhibiting a 90% homology with the chloroplast of a plant known other than the Tobacco (Accession Number X12745 M28017), Atropa Belladonna Linne (Accession Number AJ316582) (Fig. 1) . The verified DNA fragments of the Panax ginseng were searched for the most suitable primer compositing location by utilizing the primer 3 program, and three types of Ginseng marker primers (SIMGS, SIM2, and SIMSP) were synthesized.
Preparation of Ginseng Maker Primer The SIMSP primer was designed to amplify the entire 359 bp Panax ginseng DNA fragment (Fig. 2) , the SIMGS primer to amplify a shorter region of about 210 bp, and the SIM2 primer to amplify about 290 bp (Fig. 2) . Panax ginseng belongs to the Araliaceae. To test the reliability of these primers we extracted DNA from 7 varied Araliaceae, i.e., Acanthopanax divaricatus, Acanthopanax senticosus, Aralia elata, Acanthopanax sessiliflorum, Acanthopanax senticosus, Acanthopanax gracillstylus, and Acanthopanax japonicus (Japanese) as well as 40 types of medicinal plants, and amplified them using 3 of the three Ginseng marker primers. The 290 bp Panax ginseng fragment was specifically amplified from Panax giseng by the SIM2 primer (Figs. 3a, b) , and the DNAs extracted from the Bupleurum falcatum and Atractylodes rhizome also generated a small amount of product (Fig. 3a) . No PCR product was obtained with wellknown medicinal plants such as Glycyrrhiza glabra, Cinnamomum cassia, and Angelica gigas (Fig. 3b) . However, Atractylodes rhizome appeared a strong DNA band unlike Bupleurum falcatum. In order to discriminate between the PCR product of Panax ginseng (A) and that of Atractylodes rhizome (C) we analyzed the sequences of the two DNA fragment They turned out to be 99% homologous, but we found a HpyCH4 IV restriction enzyme site in the 1% of Atractylodes rhizome DNA not homologous with P. ginseng (Fig. 4) . Therefore, the products amplified by SIM2 from Panax ginseng and Atractylodes rhizome can be distinguished by RFLP analysis (Fig. 5) . ) the 290 bp DNA fragments were amplified at 50-60°C, while in the Sok-Moung-Tang ( ) without the Panax ginseng not amplified (Fig. 6 ). In addition, in the extract granulations of prescriptions such as the currently marketed Bak-Ho-GaInsam-Tang ( ) etc., the DNA was amplified using the gradient PCR as the same conditions of above. As result, all of the 14 herbal medicine preparations containing Panax ginseng , i.e., Ga-Mi-Gue-Bi-Tang (
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), Sok-Moung-Tang ( ), Siho-Ga-Yongol-Moryu-Tang ( ), and Sa-Gun-Za-Tang ( ), revealed the amplification of 290 bp Panax species DNA fragments ( ). In addition, there are 16 herbal medicine preparations non-containing the Panax ginseng including Kwak-Hyang-Jung-Gi-
), and Gaegi-Ga-Yongoal-Moryo-Tang ( ). Among them, 12 herbal medicine preparations excluding Bangpoong-Tong-Sung-San ( ), An-Jung-San ( ), Dae-Siho-Tang ( ), and Siho-GaegiGunkang-Tang ( ) (Fig. 7b) showed no signals of the amplified 290 bp Panax species DNA fragment. Thus, Bangpoong-Tong-Sung-San ( ), Dae-Siho-Tang ( ), Siho-Gaegi-Gunkang-Tang ( ), An-Jung-San ( ), and others are Panax ginseng nonconsisting and still showed the amplified 290 bp Panax species DNA fragments (Fig. 8) . In the case of the Panax ginseng non-containing medicine preparation, when the DNA was amplified using the gradient PCR method in 1-3 specific temperature range among 12 steps of temperature range, the amplified band could be a false-positive. However, in the herbal medicine preparations containing Panax gin- seng the 290 bp Panax species DNA fragments were amplified in broad annealing temperature ranges. Therefore, the false-positive reaction was discriminated by the annealing temperature range of the gradient PCR method. From the identification method of Panax ginseng using the Gradient PCR method, the most suitable annealing temperature for the SIM2 primer used as a Ginseng marker was 57°C. On the gradient PCR temperature range between 50 and 60°C, 12 steps of the annealing temperature were determined based on this range. Therefore, as a result to the gradient PCR, the 290 bp DNA fragments of the Panax ginseng were amplified equivalently overall in 50-60°C (Fig. 7a) , while the Panax ginseng 290 bp DNA fragments not amplified on the noncontaining resource (Fig. 7b) . Morever, when the 290 bp DNA fragments were amplified only in a specific temperature, the amplification result of Panax ginseng non-containing medicine preparations was interpreted as a false-positive (Fig. 8) .
The gradient PCR analysis was used to identify Panax ginseng in herbal medicine preparations using Ginseng marker primer (SIM2). In the samples of some herbal medicine preparations the Panax ginseng DNA fragments were not amplified because of the DNA sample concentration and PCR conditions. The longer the annealing time of the PCR was, the less the specification of the amplification was (data not shown). The DNA was amplified most sensitively by the SIMGS among the Ginseng marker primers but the medicinal plants other than the Panax species were also amplified frequently (data not shown). The SIMSP was synthesized to be able to amplify the largest DNA fragment (359 bp) among the Ginseng marker primer (Fig. 2) , but had the problem of amplifying only the DNA of the Panax species and lost the sensitivity to the herbal medicine preparations containing Panax ginseng. SIM2 primer used in this experiment was synthesized to amplify the DNA fragment (290 bp). The Panax ginseng specific DNA fragments were amplified precisely in the herbal medicines and herbal medicine preparations. Therefore, the SIM2 primer was chosen for the amplification in this experiment. Because it was difficult to measure the Panax ginseng DNA concentration among the total DNA concentration extracted from herbal medicine preparation, it was impossible to establish the fixed PCR reaction conditions. To overcome the problems of the PCR condition, the gradient PCR method was performed in this experiment by changing the annealing temperature in a certain thermostatic range.
The established Ginseng marker primer (SIM2) was used to perform PCR on 40 types of medicinal plants including the 7 types of Araliaceae currently used as medication, and as a result, the DNA fragments of Bupleurum falcatum and Atractylodes rhizome were amplified. However, in the case of Bupleurum falcatum, the amplified DNA fragment was not reproducible and the intensity of the amplified band is also extremely low (Fig. 3a) . Therefore, Panax ginseng was easily discriminated from the Bupleurum falcatum by the gradient PCR method using the SIM2 primer. A portion of the Atractylodes rhizome gene was prominently amplified and it was undefinable from the Panax ginseng with only the PCR results. However, the Panax species were differentiated by the RFLP method (Fig. 4) . In addition, the herb medicine components were mixed and extracted in 90-100°C for 3 h as same condition of the pharmaceutical companies manufacturing process. The DNA of the Panax species was amplified using the gradient PCR to distinguish the Panax ginseng consisting from the Panax ginseng non-consisting among the extract granulate currently circulating.
The results of the gradient PCR indicate that for the Panax ginseng consisting items, the 290 bp original DNA fragments of the Panax ginseng were amplified evenly in all 12 steps of temperature (Fig. 7a) , while for the Panax ginseng non-containing items the DNA not amplified (Fig. 7b) . In addition, in the result of the gradient PCR, the 290 bp DNA fragments in the preparations not containing the Panax ginseng that were amplified in a specific temperature of only 1-3 steps among the 12 steps was considered as a false-positive reaction (Fig. 8) . Therefore, Panax ginseng consisting items could be easily distinguished from the Panax ginseng non-consisting items by the number of the amplified bands of Panax species DNA fragments. The one possibility of the DNA amplification result in the Panax ginseng non-consisting items is that the partial damage and mutation occur during the DNA extraction so that the non-specific DNA was amplified by the Ginseng marker primer. It is presumed that there are many medicinal plants that have an analogous gene to the Panax species and could react to Ginseng marker primer among the 540 species of the medicinal plants that were not able to be established by this experiment. Therefore, it is considered that if the study on Panax ginseng genes is extensively continued it is possible to find a new Ginseng marker primer that can respond to only Panax species, and that the commercial utilization of the such items as the Panax species identification kit would be possible.
It is possible to establish a scientific identification method of herbal medicinal plants and their preparations overcoming the limits of the TLC method currently utilized in the identification methods for the herbal medicine preparations. The herbal medicine preparations can especially be affected by the spots, color, and processing length through accessory agents and holding agents added along with the main components, and the more main substances there are, the more similar the color and processing length are shown. If it is possible to overcome the disadvantages of the mechanical identification tests and to develop novel molecular biological methods such as advanced PCR method, it could be a revolutional testing method of the herbal medicine preparations identification test. In addition, it could be utilized as the examiner of the other high-priced herbal medicines with issues of origins being criticized, starting with this paper as a triggering point. If the study on the identification test of herbal medicine preparations using such methods as the RAPD and gradient PCR is continued, it is assumed to be able to be applied on all other herbal medicine preparations in future. The results of this study suggest a possibility that to identify the genetical characteristics of respective herbal medicine makes possible to develop specific marker primers that react to certain herbal medicine, presenting a possibility of developing a new identification method for many herbal medicines at once during herbal medicine preparations through the gradient PCR methods. If the marker primer for a certain herbal medicine is continuously developed in future, it is presumed that there shall be great achievements on reaching a new level of quality control for herbal medicinal preparations by creating items such as identification DNA chips. 
